DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lumefantrine
Lumefantrine
Artemether-Lumefantrine (Six-Dose Regimen) for Treating Uncomplicated Falciparum Malaria (Review)
Information for the User Riamet® 20 Mg/120 Mg Tablets Artemether And
Artemether-Lumefantrine Compared to Atovaquone-Proguanil As a Treatment for Uncomplicated Plasmodium Falciparum Malaria in Travelers
Resistance to Antimalarial Drugs: Molecular, Pharmacologic, and Clinical Considerations
Traveler Information
10 Artemether-Lumefantrine for The
Malaria Treatment
Guidelines for Treatment of Malaria in the United States 1 (Based on Drugs Currently Available for Use in the United States — October 1, 2019)
Malaria Chemotherapy & Drug Resistance
A Systematic Review of the Safety and Efficacy of Artemether-Lumefantrine Against Uncomplicated Plasmodium Falciparum Malaria Du
Drug Repositioning in the Treatment of Malaria and TB
Drug Resistance in Malaria Peter B
The WHO Guidelines for the Treatment of Malaria (MTG)
COARTEM Coadministration of Strong Inducers of CYP3A4 Such As Rifampin, Carbamazepine, Tablets Safely and Effectively
In Vitro Interaction Studies Between Artemether – Lumefantrine and IJCRR Section: Healthcare Sci
Resistance to Artemisinin Combination Therapies (Acts): Do Not Forget the Partner Drug!
Coartem (Artemether/Lumefantrine) Tablets Cautiously Following Coartem Tablets; (5.1,5.2,7.6, 12.3) Initial U.S
Ministry of Health Essential Medicines List for Uganda EMLU 2007
Top View
Identification of Trypanosoma Cruzi Growth Inhibitors with Activity In
Combination Anti-Malarial Therapy and WHO Recommendations
WHO Guidance for Prevention and Treatment of Malaria in Pregnancy
Pharmaceutical Composition Comprising Artesunate, Sulfamethoxypyrazine and Pyrimethamine for Use in the Treatment of Malaria
Localization of the Human Malaria Parasite's DHFR-TS and Examining
The Cardiotoxicity of Antimalarials
E Cacy of Quinine Plus Clindamycin Versus Artemether-Lumefantrine
The Medical Letter
Antimalarial Agents
WO 2007/028413 Al
Lumefantrine, an Antimalarial Drug, Reverses Radiation and Temozolomide Resistance in Glioblastoma
Study Protocol and Statistical Analysis Plan
Belize Drug Formulary and Therapeutics Manual
Recommendations for the Treatment and Prevention of Malaria : Update for the 2015 Season in South Africa: SAMJ March 2015 Vol 10
Other Review(S)
Coartem® at Cost Price to Malaria Endemic Countries Has Come to Its End
Updated CDC Recommendations for Using Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in Pregnant Women in the United States
Drug Repurposing and Human Parasitic Protozoan Diseases ⇑ ⇑ Katherine T
Evidence Summary: Systematic Review of Oral Fexinidazole As First Line Treatment for Gambiense Human African Trypanosomiasis
Efficacy of Artemisinin–Lumefantrine for Treatment of Uncomplicated Malaria After More Cambridge.Org/Hyg Than a Decade of Its Use in Kenya
O0720 Mefloquine, Atovaquone/Proguanil And
In Vitro Assessment of Antiplasmodial and Antitrypanosomal Activities of Chloroform, Ethyl Acetate and Ethanol Leaf Extracts of Oedera Genistifolia
Analyzing and Controlling Pharmaceutical Expenditures
Antiparasitic Therapy
Investigating in Vitro and Ex Vivo Properties of Artemether/Lumefantrine Double-Fixed Dose Combination Lipid Matrix Tablets Prepared by Hot Fusion
Guidelines for the Treatment of Malaria
Treatment of Malaria: Guidelines for Clinicians (United States)
Antimalarial Efficacy and Drug Interactions of the Novel Semi
(12) Patent Application Publication (10) Pub. No.: US 2017/0211121 A1 Stern Et Al
Antimalarial Agents C8633-A
A Mechanism of Resistance and Mode of Action for Drugs Against Plasmodium Falciparum
WO 2017/127684 Al 27 July 2017 (27.07.2017) P O P C T
Drug List for Emergency Services Only
Treatment of Malaria: Guidelines for Clinicians (United States)
The Use of Antimalarial Drugs Against Viral Infection
Effect of Food/Beverage and Selected Drugs on the Oral Absorption of Artemether-Lumefantrine Tablet: an in Situ and in Vivo Study
NATIONAL GUIDELINES for the TREATMENT of MALARIA, SOUTH AFRICA 2018 GUIDELINES for the TREATMENT of MALARIA in SOUTH AFRICA 2018 Update
Genetic Resistance to Purine Nucleoside Phosphorylase Inhibition in Plasmodium Falciparum
Artemether-Lumefantrine (Four-Dose Regimen) for Treating Uncomplicated Falciparum Malaria (Review)
Development of Organosilane‒Containing Bioorganometallic Compounds Evaluated As Antiparasitic Agents Against Plasmodium Falciparum and Trichomonas Vaginalis
CHAPTER E26 Pharmacology of Agents Used to Treat Parasitic Infections
Artemether and Lumefantrine